The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing‐Remitting Multiple Sclerosis

BACKGROUND: Spinal cord atrophy occurs early in the multiple sclerosis (MS) disease course, is closely related to physical disability, and is a putative neuroprotective therapeutic outcome measure. OBJECTIVE: This pilot study explored glatiramer acetate (GA)’s effect on spinal cord volume in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhal, Tarun, Tauhid, Shahamat, Hurwitz, Shelley, Neema, Mohit, Bakshi, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248648/
https://www.ncbi.nlm.nih.gov/pubmed/27466943
http://dx.doi.org/10.1111/jon.12378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248648/
https://www.ncbi.nlm.nih.gov/pubmed/27466943
http://dx.doi.org/10.1111/jon.12378

Ejemplares similares